<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font18">for </span>
   <span class="font17">clinical </span>
   <span class="font15">development </span>
   <span class="font14">drugs </span>
   <span class="font13">new </span>
   <span class="font13">time </span>
   <span class="font12">was </span>
   <span class="font12">{background </span>
   <span class="font12">from </span>
   <span class="font12">have </span>
   <span class="font12">licensed </span>
   <span class="font12">that </span>
   <span class="font12">regulatory </span>
   <span class="font12">trials </span>
   <span class="font11">were </span>
   <span class="font11">The </span>
   <span class="font11">margin </span>
   <span class="font11">study </span>
   <span class="font11">{border-style </span>
   <span class="font11">period </span>
   <span class="font11">drug </span>
   <span class="font11">px;} </span>
   <span class="font11">trial </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">between </span>
   <span class="font11">this </span>
   <span class="font11">This </span>
   <span class="font11">antiviral </span>
   <span class="font11">with </span>
   <span class="font11">Drug </span>
   <span class="font11">increased </span>
   <span class="font11">not </span>
   <span class="font11">those </span>
   <span class="font11">data </span>
   <span class="font11">all </span>
   <span class="font11">approval </span>
   <span class="font11">other </span>
   <span class="font11">research </span>
   <span class="font11">spent </span>
   <span class="font11">viral </span>
   <span class="font11">may </span>
   <span class="font11">taken </span>
   <span class="font11">which </span>
   <span class="font10">However, </span>
   <span class="font10">mean </span>
   <span class="font10">HIV </span>
   <span class="font10">are </span>
   <span class="font10">authors </span>
   <span class="font10">date </span>
   <span class="font10">duration </span>
   <span class="font10">first </span>
   <span class="font10">increase </span>
   <span class="font10">more </span>
   <span class="font10">periods </span>
   <span class="font10">but </span>
   <span class="font10">increasing </span>
   <span class="font10">infection </span>
   <span class="font10">innovative </span>
   <span class="font10">than </span>
   <span class="font10">Health </span>
   <span class="font10">access </span>
   <span class="font10">health </span>
   <span class="font10">px; </span>
   <span class="font10">total </span>
   <span class="font10">year </span>
   <span class="font10">{font-family </span>
   <span class="font10">(r=., </span>
   <span class="font10">. years </span>
   <span class="font10">European </span>
   <span class="font10">Marketing </span>
   <span class="font10">approved </span>
   <span class="font10">been </span>
   <span class="font10">drugs. </span>
   <span class="font10">durations </span>
   <span class="font10">filing </span>
   <span class="font10">font-size </span>
   <span class="font10">indicated </span>
   <span class="font10">initial </span>
   <span class="font10">into </span>
   <span class="font10">launched </span>
   <span class="font10">prior </span>
   <span class="font10">translational </span>
   <span class="font10">treat </span>
   <span class="font10">trend </span>
   <span class="font10">trends </span>
   <span class="font10">. months </span>
   <span class="font10">Application </span>
   <span class="font10">Medicines </span>
   <span class="font10">Nat </span>
   <span class="font10">New </span>
   <span class="font10">USA </span>
   <span class="font10">before </span>
   <span class="font10">double; </span>
   <span class="font10">had </span>
   <span class="font10">has </span>
   <span class="font10">hepatitis </span>
   <span class="font10">initiation </span>
   <span class="font10">only </span>
   <span class="font10">recent </span>
   <span class="font10">review </span>
   <span class="font10">these </span>
   <span class="font10">All </span>
   <span class="font10">Clin </span>
   <span class="font10">Clinical </span>
   <span class="font10">Duration </span>
   <span class="font10">IND </span>
   <span class="font10">National </span>
   <span class="font10">UK, </span>
   <span class="font10">analysis </span>
   <span class="font10">approval. </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">collab: </span>
   <span class="font10">decades </span>
   <span class="font10">different </span>
   <span class="font10">discovery </span>
   <span class="font10">evidence </span>
   <span class="font10">found </span>
   <span class="font10">infections </span>
   <span class="font10">initially </span>
   <span class="font10">longer </span>
   <span class="font10">our </span>
   <span class="font10">pathway </span>
   <span class="font10">pharmaceutical </span>
   <span class="font10">process </span>
   <span class="font10">regulators </span>
   <span class="font10">seen </span>
   <span class="font10">significant </span>
   <span class="font10">solid; </span>
   <span class="font10">statistically </span>
   <span class="font10">timeframes </span>
   <span class="font10">times </span>
   <span class="font10">where </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(%), </span>
   <span class="font10">./nrd </span>
   <span class="font10">Authorisation </span>
   <span class="font10">DiMasi </span>
   <span class="font10">Discov;:–. </span>
   <span class="font10">Kaitin </span>
   <span class="font10">LL-P </span>
   <span class="font10">NIHR </span>
   <span class="font10">Our </span>
   <span class="font10">Pharmacol </span>
   <span class="font10">R&amp;amp;D </span>
   <span class="font10">Regulatory </span>
   <span class="font10">Research </span>
   <span class="font10">Rev </span>
   <span class="font10">Ther;:–. </span>
   <span class="font10">Trials </span>
   <span class="font10">also </span>
   <span class="font10">article </span>
   <span class="font10">bold </span>
   <span class="font10">bring </span>
   <span class="font10">considered </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">development, </span>
   <span class="font10">drugs, </span>
   <span class="font10">em; </span>
   <span class="font10">half </span>
   <span class="font10">highly </span>
   <span class="font10">indication </span>
   <span class="font10">linear </span>
   <span class="font10">medicines </span>
   <span class="font10">most </span>
   <span class="font10">observed </span>
   <span class="font10">part </span>
   <span class="font10">patient </span>
   <span class="font10">period, </span>
   <span class="font10">preclinical </span>
   <span class="font10">pt;} </span>
   <span class="font10">published </span>
   <span class="font10">relevant </span>
   <span class="font10">research, </span>
   <span class="font10">studies </span>
   <span class="font10">submission </span>
   <span class="font10">submitted </span>
   <span class="font10">subsequent </span>
   <span class="font10">there </span>
   <span class="font10">though </span>
   <span class="font10">use </span>
   <span class="font10">used </span>
   <span class="font10">y=.×year—., </span>
  </p>
 </body>
</html>
